Benign Bone Tumors: An Overview of What We Know Today

Salvo, S; Pavone, Vito; Coco, Sebastiano; Dell’Agli, Eleonora; Blatti, Chiara; Testa, Gianluca

doi:10.3390/jcm11030699

Cited by 21 publications

(27 citation statements)

References 107 publications

(109 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…erefore in our study, where bone cysts accounted for 76% of all cases, in more than 23% of patients, the rst symptom of the disease was a pathological fracture. It is also worth emphasizing that benign bone lesions grow over many years, which is why they are o en diagnosed accidentally due to performing a radiograph for another reason [22]. In our study, half of the patients didn't know about the tumors in the bone before performing an X-ray on account of injury.…”

Section: Discussionmentioning

confidence: 77%

“…e main limitation of our study is the sample size, but this is due to a fact of a low occurrence of benign bone tumors in the general population, and with some of them giving close to no clinical implications, the number of correctly diagnosed patients is even lower [22]. In our study, we also wanted to present the possibility of using the CER-AMENT in various cases of benign bone tumors and cysts.…”

Section: Discussionmentioning

confidence: 98%

See 1 more Smart Citation

The use of bone substitute (CERAMENT) in the treatment of benign bone tumors and tumor-like lesions

Zrodowski¹,

Ciechanowicz²,

Dembski³

et al. 2022

Chir. Narzadow Ruchu Ortop. Pol.

View full text Add to dashboard Cite

Introduction. Treatment of benign bone tumors and tumor-like lesions is undertaken by numerous Orthopedic surgeons worldwide. Several treatment modalities exist including curettage and bone grafting. CERAMENT is a novel bioresorbable bone substitute used for grafting. Aim. Assessment of preliminary result of treatment of benign bone tumors and tumors like lesions utilizing CERAMENT as a bone substitute. Analysis of therapeutic and diagnostic path and symptoms reported by patients with tumors and tumor-like lesions. Materials and methods. To the retrospective study 38 patients undergoing curettage and bone substitution with CERAMENT® BONE VOID FILLER were included (26% of them were females). We utilized patients’ history. Each patient had an X-ray in the twelfth month after surgery, which was analyzed using the modified Neer classification. The follow-up was 24 months. Results. The unicameral bone cyst was the most commonly encountered lesion (36.8%). Pain was the most common symptom reported (28.9%). Half of all cases were discovered accidentally on X-rays ordered for a different indication. Nearly a quarter of the cases (23.7%) were complicated by pathologic fracture. The distribution of scores in modified Neer score was as follow: SCORE I- 52.6% SCORE II- 15.8% SCORE III-10.6% SCORE IV-2.6%. Complications of procedure were noted in 18.4% of patients. 10.5% of patients had serious discharge from the operated site, 7.9% of patients had surgical wound infection. One case of recurrence was noted. Conclusions. Bone substitute – CERAMENT is suitable for use in the treatment of benign bone tumors and tumors like lesions. It is easy in application and is well tolerated by the patients. The problem is the relatively high rate of complications, mainly serous leakage from the wound.

show abstract

Section: Discussionmentioning

confidence: 77%

Section: Discussionmentioning

confidence: 98%

The use of bone substitute (CERAMENT) in the treatment of benign bone tumors and tumor-like lesions

Zrodowski¹,

Ciechanowicz²,

Dembski³

et al. 2022

Chir. Narzadow Ruchu Ortop. Pol.

View full text Add to dashboard Cite

show abstract

“…Diagnosis of benign osteoblastoma is difficult due to its uniqueness, perplexing clinical-radiologic presentation, and histopathologic characteristics that occasionally mimic osteosarcoma and other bone tumors. Cementoblastoma, osteoid osteoma, and benign osteoblastoma have histologic similarities, thus implying a relationship between these pathologic conditions [ 8 ]. Owing to the benign nature and location of this tumor, curettage or conservative surgical excision remains the treatment modality, and en bloc resection is seldom performed.…”

Section: Discussionmentioning

confidence: 99%

A Rare Case of Benign Osteoblastoma of the Mandible

Krishnan

Krishna

Periasamy

et al. 2022

Cureus

View full text Add to dashboard Cite

“…Osteoid osteomas are benign tumors of osseous origin, which come third in place of incidence after non-ossifying fibromas and endochondromas (De Salvo et al, 2022). They are slow growing and can occur in any bone of the face and the cranium either superficially or intraosseous6.…”

Section: Discussionmentioning

confidence: 99%

Osteoid Osteoma of The Frontal Sinus: A Case Report

Maarouf¹,

Ali²

2022

FMCR

View full text Add to dashboard Cite

An osteoid osteoma is a benign bone-forming tumor that usually causes nocturnal severe pain. The majority are found in the head and neck region and represent the most common benign neoplasm of the nose and paranasal sinuses. We report the case of a 14-year-old female patient admitted for refractory headache and diagnosed with an osteoid osteoma of the frontal sinus, which have been treated successfully using surgical intervention. As for our patient, en block wide excision was enough to resect the whole tumor as it was confined to the frontal sinus.

show abstract

Benign Bone Tumors: An Overview of What We Know Today

Cited by 21 publications

References 107 publications

The use of bone substitute (CERAMENT) in the treatment of benign bone tumors and tumor-like lesions

The use of bone substitute (CERAMENT) in the treatment of benign bone tumors and tumor-like lesions

A Rare Case of Benign Osteoblastoma of the Mandible

Osteoid Osteoma of The Frontal Sinus: A Case Report

Contact Info

Product

Resources

About